JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis
Clinical trial NCT01795677 · COMPLETED
Trial details
- NCT number
- NCT01795677
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2018-05-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.